Cargando…

The ETNK2 gene promotes progression of papillary thyroid carcinoma through the HIPPO pathway

Thyroid cancer is a disease with an extremely high incidence rate and is divided into papillary, follicular, medullary, and undifferentiated thyroid cancers. Among them, papillary carcinoma is the most common subtype. We assessed expression of ETNK2 in public databases and found that ETNK2 is upregu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Danni, Jin, Lingli, Chen, Buran, Qi, Yufeng, Bhandari, Adheesh, Wen, Jialiang, Lin, Bangyi, Zhang, Xiaohua, Zhang, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771505/ https://www.ncbi.nlm.nih.gov/pubmed/35069898 http://dx.doi.org/10.7150/jca.65587

Ejemplares similares

Immortalization up‐regulated protein promotes tumorigenesis and inhibits apoptosis of papillary thyroid cancer
por: Lin, Lizhi, et al.
Publicado: (2020)

PSD3 is an oncogene that promotes proliferation, migration, invasion, and G1/S transition while inhibits apoptotic in papillary thyroid cancer
por: Jin, Lingli, et al.
Publicado: (2021)

SYT12 is a novel oncogene that promotes thyroid carcinoma progression and metastasis
por: Jin, Lingli, et al.
Publicado: (2021)

KCNN4 is a diagnostic and prognostic biomarker that promotes papillary thyroid cancer progression
por: Wen, Jialiang, et al.
Publicado: (2020)

LEM domain containing 1 promotes thyroid cancer cell proliferation and migration by activating the Wnt/β-catenin signaling pathway and epithelial-mesenchymal transition
por: Xu, Min, et al.
Publicado: (2021)

CLDN10 is Associated with Papillary Thyroid Cancer Progression
por: Zhou, Yili, et al.
Publicado: (2018)

LINC00511 influences cellular proliferation through cyclin-dependent kinases in papillary thyroid carcinoma
por: Xiang, Jingjing, et al.
Publicado: (2020)

Glucose-to-Lymphocyte Ratio (GLR) as a Predictor of Preoperative Central Lymph Node Metastasis in Papillary Thyroid Cancer Patients With Type 2 Diabetes Mellitus and Construction of the Nomogram
por: Jin, Lingli, et al.
Publicado: (2022)

miR-708–3p promotes gastric cancer progression through downregulating ETNK1
por: Shang, Jincai, et al.
Publicado: (2023)

LncRNA PROX1-AS1 promotes proliferation, invasion, and migration in papillary thyroid carcinoma
por: Shen, Yanyan, et al.
Publicado: (2018)

Lncrna FEZf1-as1 negatively regulates ETNK1 to promote malignant progression of renal cell carcinoma
por: Lou, Jiangyong, et al.
Publicado: (2023)

CITED1 gene promotes proliferation, migration and invasion in papillary thyroid cancer
por: Xia, Erjie, et al.
Publicado: (2018)

Eva‐1 homolog A promotes papillary thyroid cancer progression and epithelial‐mesenchymal transition via the Hippo signalling pathway
por: Lin, Bang‐Yi, et al.
Publicado: (2020)

Original tumour suppressor gene polycystic kidney and hepatic disease 1-like 1 is associated with thyroid cancer cell progression
por: Zheng, Chen, et al.
Publicado: (2019)

ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine
por: Fontana, Diletta, et al.
Publicado: (2020)

Uridine phosphorylase 1 associates to biological and clinical significance in thyroid carcinoma cell lines
por: Guan, Yaoyao, et al.
Publicado: (2019)

ETNK2 Low-Expression Predicts Poor Prognosis in Renal Cell Carcinoma with Immunosuppressive Tumor Microenvironment
por: Chu, Jian, et al.
Publicado: (2023)

Synaptopodin-2 plays an important role in the metastasis of breast cancer via PI3K/Akt/mTOR pathway
por: Xia, Erjie, et al.
Publicado: (2018)

Novel recurrent mutations in ethanolamine kinase 1 (ETNK1) gene in systemic mastocytosis with eosinophilia and chronic myelomonocytic leukemia
por: Lasho, T L, et al.
Publicado: (2015)

Growth‐associated protein 43 promotes thyroid cancer cell lines progression via epithelial‐mesenchymal transition
por: Zheng, Chen, et al.
Publicado: (2019)

Expression of Hippo Pathway in Colorectal Cancer
por: Liang, Kun, et al.
Publicado: (2014)

Targeting loss of the Hippo signaling pathway in NF2-deficient papillary kidney cancers
por: Sourbier, Carole, et al.
Publicado: (2018)

Fibrinogen-to-Neutrophil Ratio as a New Predictor of Central Lymph Node Metastasis in Patients with Papillary Thyroid Cancer and Type 2 Diabetes Mellitus
por: Zheng, Danni, et al.
Publicado: (2022)

Long Noncoding RNA CCAL Promotes Papillary Thyroid Cancer Progression by Activation of NOTCH1 Pathway
por: Ye, Ying, et al.
Publicado: (2018)

CD73 Overexpression Promotes Progression and Recurrence of Papillary Thyroid Carcinoma
por: Jeong, Young Mun, et al.
Publicado: (2020)

Ezrin promotes esophageal squamous cell carcinoma progression via the Hippo signaling pathway
por: Ma, Lijuan, et al.
Publicado: (2023)

HLF promotes ovarian cancer progression and chemoresistance via regulating Hippo signaling pathway
por: Han, Tao, et al.
Publicado: (2023)

ANGPTL4 Promotes the Proliferation of Papillary Thyroid Cancer via AKT Pathway
por: Yang, Longyan, et al.
Publicado: (2020)

CD155 promotes radioresistance and malignancy of esophageal cancer by regulating Hippo-YAP pathway
por: Xin, Huixian, et al.
Publicado: (2022)

The crosstalk between lncRNAs and the Hippo signalling pathway in cancer progression
por: Tu, Chao, et al.
Publicado: (2020)

The Hippo pathway in endometrial cancer: a potential therapeutic target?
por: Shen, Xinyun, et al.
Publicado: (2023)

Evidence of Cooperation between Hippo Pathway and RAS Mutation in Thyroid Carcinomas
por: Carneiro, Thaise Nayane Ribeiro, et al.
Publicado: (2021)

SEC61G regulates breast cancer cell proliferation and metastasis by affecting the Epithelial-Mesenchymal Transition
por: Jin, Lingli, et al.
Publicado: (2022)

TROP2 modulates the progression in papillary thyroid carcinoma
por: Sun, Huali, et al.
Publicado: (2021)

DNAJB4 suppresses breast cancer progression and promotes tumor immunity by regulating the Hippo signaling pathway
por: Chen, Yanru, et al.
Publicado: (2023)

Scavenger receptor class A, member 5 is associated with thyroid cancer cell lines progression via epithelial‐mesenchymal transition
por: Zheng, Chen, et al.
Publicado: (2020)

CDK12 promotes papillary thyroid cancer progression through regulating the c-myc/β-catenin pathway
por: Bai, Ning, et al.
Publicado: (2020)

Hippo pathway inhibition promotes metabolic adaptability and antioxidant response in myoblasts
por: Liu, Qi, et al.
Publicado: (2023)

Hippo pathway dysregulation in gastric cancer: from Helicobacter pylori infection to tumor promotion and progression
por: Messina, Beatrice, et al.
Publicado: (2023)

CENPF promotes papillary thyroid cancer progression by mediating cell proliferation and apoptosis
por: Han, Yong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u4j0rmoeqml4ei055rtf2sa88j